You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 7,507,703

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,507,703

Title:	Method of cancer screening; method of cancer treatment; and method of diabetes treatment
Abstract:	A method of cancer screening comprising the steps of administering the Blood CA 27,29 testing procedure; if the result is positive administering a mammogram; if the result is positive administering a needle biopsy; if the result is positive administering a PET scan; if the result is positive administering a blood tumor cell count. If all of the foregoing steps are positive, the cancer is treated by applying imiquimod transdermally to rotating sites, preferably by mixing ALDARA.TM. (imiquimod) 5% cream with an equal amount of H base cream.TM.; administering a vaccine that induces production of tumor necrosis factor, preferably the BCG vaccine; and orally administering VALTREX.TM. valacyclovir twice daily. The foregoing treatment method is also effective in treating Type I diabetes, MS, and other epidermal cancers.
Inventor(s):	Woodward; John R. (Dallas, TX)
Assignee:	Woodward; John R. (Dallas, TX)
Application Number:	11/533,805
Patent Claims:	1. A method of treating duct cell breast cancer in a patient comprising the steps of: providing a quantity of ALDARA.TM. (imiquimod) 5% cream; providing a quantity of H base cream.TM.; mixing 1/4 cc. of the ALDARA.TM. (imiquimod) 5% cream with 1/4 cc. of the H base cream.TM.; transdermally administering the resulting mixture, in conjunction with administering BCG vaccine; and orally administering VALTREX.TM. (valacyclovir) tablets, to the patient; and monitoring the procedure using the Blood CA 27,29 testing procedure. 2. The method of treating duct cell breast cancer according to claim 1 wherein the BCG vaccine is administered every three weeks. 3. The method of treating duct cell breast cancer according to claim 2 wherein the 500 mg VALTREX.TM. (valacyclovir) are orally administered twice daily.

Details for Patent 7,507,703

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Teknika Llc	N/A	bcg vaccine	For Injection	103050	06/21/1989	⤷ Try a Trial	2024-09-21
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.